Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis

Trial Profile

Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Ferric pyrophosphate (Primary) ; Ferric pyrophosphate
  • Indications Anaemia
  • Focus Pharmacokinetics
  • Sponsors Rockwell Medical Technologies
  • Most Recent Events

    • 30 Oct 2017 According to a Rockwell Medical India media release, data from the study will be presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.
    • 04 Aug 2017 Status changed from not yet recruiting to completed.
    • 29 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top